Sun Pharma expects 18-20% FY13 sales growth

Mumbai: Sun Pharmaceutical Industries Ltd expects 18-20% sales growth in the current fiscal year that started in April, managing director Dilip Shanghvi said in an earnings conference call on Wednesday.

On Tuesday, the company reported an 85% jump in quarterly profit to Rs 820 crore ($146 million).

Also Read | Taro boosts Sun Pharma Q4 net profit